Christopher Moore
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Physiology 11
- Pain Mechanisms and Treatments 3
- Nitric Oxide and Endothelin Effects 3
- Voice and Speech Disorders 3
- Co-authors
- Julian Downward (12 shared papers)Sareena Rana (10 shared papers)Míriam Molina‐Arcas (9 shared papers)Bradley Spencer‐Dene (3 shared papers)Philip East (4 shared papers)Emma Nye (2 shared papers)Davide Zecchin (2 shared papers)Sophie de Carné Trécesson (3 shared papers)
- Journals
- Nature Communications (3 papers)Cancer Research (3 papers)Clinical Neurophysiology (2 papers)European Journal of Pharmacology (2 papers)British Journal of Pharmacology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Christopher Moore
49 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Immunology 465
- Oncology 589
- Molecular Biology 906
- Hepatology 102
- Cancer Research 158
Countries citing papers authored by Christopher Moore
This map shows the geographic impact of Christopher Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Moore more than expected).
Fields of papers citing papers by Christopher Moore
This network shows the impact of papers produced by Christopher Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Moore. The network helps show where Christopher Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA Hit paper breakdown → | 2017 | 474 |
| 2 | 2005 | 186 | |
| 3 | 2019 | 146 | |
| 4 | 2013 | 139 | |
| 5 | 2013 | 119 | |
| 6 | 2019 | 90 | |
| 7 | 2022 | 73 | |
| 8 | 2010 | 53 | |
| 9 | 2022 | 46 | |
| 10 | 2019 | 46 | |
| 11 | 1986 | 43 | |
| 12 | 2009 | 42 | |
| 13 | 2021 | 41 | |
| 14 | 2021 | 40 | |
| 15 | 2000 | 38 | |
| 16 | 2008 | 38 | |
| 17 | 2020 | 35 | |
| 18 | 1991 | 34 | |
| 19 | 1995 | 32 | |
| 20 | 1988 | 31 |
About Christopher Moore
Christopher Moore is a scholar working on Molecular Biology, Physiology, Pulmonary and Respiratory Medicine, Oncology and Cellular and Molecular Neuroscience, having authored 53 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Platelet Disorders and Treatments (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Pain Mechanisms and Treatments (3 papers), Nitric Oxide and Endothelin Effects (3 papers) and Voice and Speech Disorders (3 papers). The work is most often cited by research in Immunology (465 citations), Oncology (589 citations), Molecular Biology (906 citations), Hepatology (102 citations) and Cancer Research (158 citations). Christopher Moore has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Julian Downward, Sareena Rana, Míriam Molina‐Arcas, Bradley Spencer‐Dene, Philip East, Emma Nye, Davide Zecchin, Sophie de Carné Trécesson, Karin Barnouin and Perry J. Blackshear. Their work appears in journals such as Nature Communications, Cancer Research, Clinical Neurophysiology, European Journal of Pharmacology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.